Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.

Hoxha A, Favaro M, Calligaro A, Del Ross T, Ruffatti AT, Infantolino C, Tonello M, Mattia E, Ruffatti A.

Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697665. [Epub ahead of print]

PMID:
31634958
2.

Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus.

Larosa M, Del Ross T, Calligaro A, Favaro M, Zanatta E, Iaccarino L, Doria A.

Expert Rev Clin Immunol. 2019 Jun;15(6):617-627. doi: 10.1080/1744666X.2019.1601557. Epub 2019 Apr 19.

PMID:
30933534
3.

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.

Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.

Thromb Res. 2019 May;177:157-160. doi: 10.1016/j.thromres.2019.03.006. Epub 2019 Mar 8.

PMID:
30903876
4.

Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab.

Ruffatti A, Tarzia V, Fedrigo M, Calligaro A, Favaro M, Macor P, Tison T, Cucchini U, Cosmi E, Tedesco F, Angelini A, Gerosa G.

Autoimmun Rev. 2019 May;18(5):561-563. doi: 10.1016/j.autrev.2019.03.015. Epub 2019 Mar 4. No abstract available.

PMID:
30844561
5.

Management of pregnant women with antiphospholipid antibodies.

Ruffatti A, Favaro M, Calligaro A, Zambon A, Del Ross T.

Expert Rev Clin Immunol. 2019 Apr;15(4):347-358. doi: 10.1080/1744666X.2019.1565995. Epub 2019 Jan 11.

PMID:
30616398
6.

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.

Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V.

J Autoimmun. 2018 Sep;93:124-130. doi: 10.1016/j.jaut.2018.07.001. Epub 2018 Jul 7.

PMID:
30146007
7.

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.

Tonello M, Mattia E, Del Ross T, Favaro M, Calligaro A, Hoxha A, Bison E, Pengo V, Ruffatti A.

Clin Chim Acta. 2018 Oct;485:74-78. doi: 10.1016/j.cca.2018.06.037. Epub 2018 Jun 25.

PMID:
29953850
8.

In Vitro Evaluation of the Sensitivity of a Hyaluronic Acid PEG Cross-Linked to Bovine Testes Hyaluronidase.

Zerbinati N, Lotti T, Monticelli D, Martina V, Cipolla G, D'Este E, Calligaro A, Mocchi R, Maccario C, Sommatis S, Lotti J, Wollina U, Tchernev G, França K.

Open Access Maced J Med Sci. 2018 Jan 21;6(1):20-24. doi: 10.3889/oamjms.2018.046. eCollection 2018 Jan 25.

9.

In Vitro Evaluation of the Biosafety of Hyaluronic Acid PEG Cross-Linked with Micromolecules of Calcium Hydroxyapatite in Low Concentration.

Zerbinati N, Lotti T, Monticelli D, Rauso R, González-Isaza P, D'Este E, Calligaro A, Sommatis S, Maccario C, Mocchi R, Lotti J, Wollina U, Tchernev G, França K.

Open Access Maced J Med Sci. 2018 Jan 7;6(1):15-19. doi: 10.3889/oamjms.2018.044. eCollection 2018 Jan 25.

10.

Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO2 Laser Treatment.

Salvatore S, França K, Lotti T, Parma M, Palmieri S, Candiani M, D'Este E, Viglio S, Cornaglia AI, Farina A, Riva F, Calligaro A, Lotti J, Wollina U, Tchernev G, Zerbinati N.

Open Access Maced J Med Sci. 2018 Jan 19;6(1):6-14. doi: 10.3889/oamjms.2018.058. eCollection 2018 Jan 25.

11.

Topical Immunotherapy of Alopecia Areata: A Large Retrospective Study.

Zerbinati N, Esposito C, D'Este E, Calligaro A, Valsecchi R.

Dermatol Ther (Heidelb). 2018 Mar;8(1):101-110. doi: 10.1007/s13555-018-0226-5. Epub 2018 Feb 13.

12.

Calcium hydroxylapatite treatment of human skin: evidence of collagen turnover through picrosirius red staining and circularly polarized microscopy.

Zerbinati N, Calligaro A.

Clin Cosmet Investig Dermatol. 2018 Jan 15;11:29-35. doi: 10.2147/CCID.S143015. eCollection 2018.

13.

Thrombocytopenia in high-risk patients with antiphospholipid syndrome.

Pontara E, Banzato A, Bison E, Cattini MG, Baroni G, Denas G, Calligaro A, Marson P, Tison T, Ruffatti A, Pengo V.

J Thromb Haemost. 2018 Mar;16(3):529-532. doi: 10.1111/jth.13947. Epub 2018 Jan 25.

PMID:
29316193
14.

Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays.

Mattia E, Hoxha A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ghirardello A, Ruffatti A.

Clin Chem Lab Med. 2018 May 24;56(6):927-932. doi: 10.1515/cclm-2017-0704.

PMID:
29303768
15.

A new hyaluronic acid polymer in the augmentation and restoration of labia majora.

Zerbinati N, Haddad RG, Bader A, Rauso R, D'Este E, Cipolla G, Calligaro A, Gonzalez P, Salvatore S, Serafin D.

J Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):153-161.

PMID:
28702976
16.

Clinical and histological changes in Hidradenitis suppurativa following 1064 nm nd:YAG intralesional laser treatment.

Zerbinati N, D'Este E, Ini L, Baruffato A, Premoli V, Calligaro A, Paulli M.

J Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):131-140.

PMID:
28702973
17.

In vitro evaluation of collagen production on human fibroblasts treated with hyaluronic acid peg cross-linked with micromolecules of calcium hydroxyapatite in low concentration.

Zerbinati N, Rauso R, Gonzalez P, Cherubino M, D'Este E, Calligaro A, Sommatis S, Maccario C, Mocchi R.

J Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):87-90.

PMID:
28702968
18.

Morphological evidences following pegylated filler treatment in human skin.

Zerbinati N, D'Este E, Farina A, Rauso R, Cherubino M, Calligaro A.

J Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):79-85.

PMID:
28702967
19.

Functional topography of the fully grown human oocyte.

Monti M, Calligaro A, Behr B, Rejo Pera R, Redi CA, Wossidlo M.

Eur J Histochem. 2017 Feb 6;61(1):2769. doi: 10.4081/ejh.2017.2769.

20.

Microscopic and ultrastructural evidences in human skin following calcium hydroxylapatite filler treatment.

Zerbinati N, D'Este E, Parodi PC, Calligaro A.

Arch Dermatol Res. 2017 Jul;309(5):389-396. doi: 10.1007/s00403-017-1734-3. Epub 2017 Mar 21.

21.

Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.

Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, Calligaro A, Elias JA, Gambaciani M, Gaviria JE, Iglesia CB, Selih-Martinec K, Mwesigwa PL, Ogrinc UB, Salvatore S, Scollo P, Zerbinati N, Nelson JS.

Lasers Surg Med. 2017 Feb;49(2):137-159. doi: 10.1002/lsm.22637. Epub 2017 Feb 21. Review.

22.

Skin Treatment with Pulsed Monochromatic UVA1 355 Device and Computerized Morphometric Analysis of Histochemically Identified Langerhans Cells.

Zerbinati N, Riva F, Paulli M, Parodi PC, Calligaro A.

Biomed Res Int. 2016;2016:3415136. doi: 10.1155/2016/3415136. Epub 2016 Jul 20.

23.

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A, Argolini LM, Kumar R, Pengo V, Meroni PL, Ruffatti A, Tincani A.

Immunol Res. 2017 Feb;65(1):17-24. doi: 10.1007/s12026-016-8812-z.

PMID:
27406736
24.

Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.

Ruffatti A, Cerutti A, Favaro M, Del Ross T, Calligaro A, Hoxha A, Marson P, Leoni L, Milanesi O.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):706-13. Epub 2016 Jun 22.

PMID:
27385463
25.

Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study.

Hoxha A, Calligaro A, Di Poi E, Peccatori S, Favaro M, Del Ross T, Ramonda R, Grava C, Raffeiner B, Ravagni P, De Vita S, Ruffatti A.

Joint Bone Spine. 2017 Mar;84(2):169-173. doi: 10.1016/j.jbspin.2016.03.014. Epub 2016 Jun 22.

PMID:
27344079
26.

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.

Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Del Ross T, Calligaro A, Tonello M, Nardelli GB.

J Reprod Immunol. 2016 Jun;115:14-9. doi: 10.1016/j.jri.2016.03.004. Epub 2016 Mar 29.

PMID:
27088752
27.

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.

Tonello M, Ruffatti A, Favaro M, Tison T, Del Ross T, Calligaro A, Hoxha A, Mattia E, Punzi L.

Lupus Sci Med. 2016 Mar 24;3(1):e000129. doi: 10.1136/lupus-2015-000129. eCollection 2016.

28.

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study.

Hoxha A, Calligaro A, Tonello M, Ramonda R, Carletto A, Paolazzi G, Bortolotti R, Del Ross T, Grava C, Boaretto M, Favaro M, Teghil V, Ruffatti A, Punzi L.

Joint Bone Spine. 2016 Mar;83(2):167-71. doi: 10.1016/j.jbspin.2015.04.020. Epub 2015 Dec 29.

PMID:
26750762
29.

Successful Reconstruction of Nerve Defects Using Distraction Neurogenesis with a New Experimental Device.

Yousef MA, Dionigi P, Marconi S, Calligaro A, Cornaglia AI, Alfonsi E, Auricchio F.

Basic Clin Neurosci. 2015 Oct;6(4):253-64.

30.

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.

Ruffatti A, Favaro M, Brucato A, Ramoni V, Facchinetti M, Tonello M, Del Ross T, Calligaro A, Hoxha A, Grava C, De Silvestro G.

Transfus Apher Sci. 2015 Dec;53(3):269-78. doi: 10.1016/j.transci.2015.11.006. Epub 2015 Nov 25. Review.

PMID:
26626966
31.

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.

Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, Facchinetti M, Hoxha A, Punzi L.

Thromb Res. 2015 Nov;136(5):883-6. doi: 10.1016/j.thromres.2015.08.019. Epub 2015 Sep 5.

PMID:
26410418
32.

Are biological drugs safe in pregnancy?

Calligaro A, Hoxha A, Ruffatti A, Punzi L.

Reumatismo. 2015 Mar 31;66(4):304-17. doi: 10.4081/reumatismo.2014.798. Review.

33.

Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study.

Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A, Zerbinati N.

Menopause. 2015 Aug;22(8):845-9. doi: 10.1097/GME.0000000000000401.

PMID:
25608269
34.

Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.

Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, Saitta S, Calagna G.

Maturitas. 2015 Mar;80(3):296-301. doi: 10.1016/j.maturitas.2014.12.006. Epub 2014 Dec 25.

PMID:
25596815
35.

Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment.

Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, Marotta F, Calligaro A.

Lasers Med Sci. 2015 Jan;30(1):429-36. doi: 10.1007/s10103-014-1677-2. Epub 2014 Nov 20.

PMID:
25410301
36.

A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.

Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U.

Climacteric. 2014 Aug;17(4):363-9. doi: 10.3109/13697137.2014.899347. Epub 2014 Jun 5.

PMID:
24605832
37.

Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.

Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, Morgan J, Calligaro A, Casasco A, Orlacchio A, Gijsbers R, D'Hooge J, Toelen J, Janssens S, Sampaolesi M.

J Am Heart Assoc. 2013 Aug 20;2(4):e000284. doi: 10.1161/JAHA.113.000284.

38.

Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.

Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L.

J Rheumatol. 2013 Apr;40(4):425-9. doi: 10.3899/jrheum.120576. Epub 2013 Feb 15.

PMID:
23418380
39.

A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature.

Ruffatti A, Marson P, Svaluto-Moreolo G, Marozio L, Tibaldi M, Favaro M, Calligaro A, Grava C, Hoxha A, Pengo V, Punzi L.

Autoimmun Rev. 2013 May;12(7):768-73. doi: 10.1016/j.autrev.2013.01.002. Epub 2013 Jan 20. Review.

PMID:
23340276
40.

Developmental arrest and mouse antral not-surrounded nucleolus oocytes.

Monti M, Zanoni M, Calligaro A, Ko MS, Mauri P, Redi CA.

Biol Reprod. 2013 Jan 3;88(1):2. doi: 10.1095/biolreprod.112.103887. Print 2013 Jan.

41.

Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature.

Caverzasi E, Pichiecchio A, Poloni GU, Calligaro A, Pasin M, Palesi F, Castellazzi G, Pasquini M, Biondi M, Barale F, Bastianello S.

Funct Neurol. 2012 Jan-Mar;27(1):13-22. Review.

42.

Risk-based secondary prevention of obstetric antiphospholipid syndrome.

Ruffatti A, Calligaro A, Del Ross T, Favaro M, Tonello M, Banzato A, Punzi L, Pengo V.

Lupus. 2012 Jun;21(7):741-3. doi: 10.1177/0961203312446388.

PMID:
22635219
43.

Cobalamin (vitamin B(12)) regulation of PrP(C), PrP(C)-mRNA and copper levels in rat central nervous system.

Scalabrino G, Veber D, Mutti E, Calligaro A, Milani S, Tredici G.

Exp Neurol. 2012 Jan;233(1):380-90. doi: 10.1016/j.expneurol.2011.11.003. Epub 2011 Nov 12.

PMID:
22116041
44.

The octapeptide repeat PrP(C) region and cobalamin-deficient polyneuropathy of the rat.

Scalabrino G, Mutti E, Veber D, Rodriguez Menendez V, Novembrino C, Calligaro A, Tredici G.

Muscle Nerve. 2011 Dec;44(6):957-67. doi: 10.1002/mus.22225.

PMID:
22102467
45.

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.

Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT, Cuffaro S, Pengo V, Punzi L.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):302-7. doi: 10.1002/acr.20098.

46.

Growth and stratification of epithelial cells in minimal culture conditions.

Riva F, Casasco A, Casasco M, Calligaro A, Cornaglia AI.

Methods Mol Biol. 2010;585:25-43. doi: 10.1007/978-1-60761-380-0_3.

PMID:
19907994
47.

How Camillo Golgi became "the Golgi".

Mazzarello P, Garbarino C, Calligaro A.

FEBS Lett. 2009 Dec 3;583(23):3732-7. doi: 10.1016/j.febslet.2009.10.018. Epub 2009 Oct 13.

48.

Complications in major depressive disorder therapy: a review of magnetic resonance spectroscopy studies.

Caverzasi E, Pichiecchio A, Calligaro A, Pasin M, Giugni E, Pasquini M, Biondi M, Barale F, Bastianello S.

Funct Neurol. 2008 Jul-Sep;23(3):129-32. Review.

PMID:
19152732
49.

The antiphospholipid syndrome and infections in a child with trisomy 21.

Hoxha A, Calligaro A, Bortolati M, Tonello M, Guariso G, Ruffatti A.

Autoimmun Rev. 2008 Dec;8(2):121-3. doi: 10.1016/j.autrev.2008.05.004. Epub 2008 Jun 23.

PMID:
18573354
50.

Generation of human epidermal constructs on a collagen layer alone.

Riva F, Casasco A, Nespoli E, Cornaglia AI, Casasco M, Faga A, Scevola S, Mazzini G, Calligaro A.

Tissue Eng. 2007 Nov;13(11):2769-79.

PMID:
17931165

Supplemental Content

Loading ...
Support Center